Introduction {#s1}
============

Our sense of touch relies on mechanotransduction, that is the conversion of mechanical stimuli to electrical signals in primary afferent sensory neurons of the somatosensory system. Piezo2 ion channels have emerged as major somatosensory mechanotransducers and mediate rapidly adapting mechanically activated (RA-MA) currents in sensory neurons, such as those of dorsal root ganglia (DRG) ([@bib16], [@bib18]). By now it has been established that Piezo2 is crucially involved in vertebrate light touch and proprioception ([@bib16], [@bib18]; [@bib27]; [@bib68]; [@bib82]; [@bib83]). Despite its importance, the regulation of native Piezo2 is only beginning to be elucidated. Mechanistically, several scenarios might be at play ([@bib85]): direct action of phospholipids, the modulation of local membrane properties and protein-protein interactions, just to name a few. Studies on other mechanosensitive ion channels such as the family of small conductance channels (MscS) ([@bib75]) as well as eukaryotic TRAAK, TREK1 ([@bib11], [@bib12]) and Piezo1 ([@bib19]; [@bib45]; [@bib84]) demonstrated their direct interplay with components of the lipid bilayer. In case of Piezo2, RA-MA currents were shown to be inhibited through depletion of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P~2~) and phosphatidylinositol 4-monophosphate (PI(4)P) ([@bib10]), and also by depletion of cholesterol at the plasma membrane ([@bib66]). Besides, lipid- or cytoskeleton-induced changes in plasma membrane tension have been shown to impact somatosensory mechanotransduction ([@bib38]; [@bib56]; [@bib66]). In contrast to the vast knowledge of the molecular network governing mechanotransduction in the nematode C. elegans, to date only few protein-protein interactions relevant for Piezo2 physiology have been identified in vertebrates. These include stomatin-like protein STOML3 ([@bib63]; [@bib66]; [@bib81]), unidentified protein tethers to the extracellular matrix ([@bib34]) and Pericentrin ([@bib57]). It is noteworthy that all of these exhibit pronounced effects on the magnitude or mechanical sensitivity of Piezo2 RA-MA currents.

In order to advance the molecular understanding of Piezo2 regulation, we recently performed an interactomics screen, which revealed several additional binding partners of native Piezo2 in murine DRG ([@bib57]). A significantly enriched and prominent member of the Piezo2 interactome was myotubularin related protein 2 (Mtmr2) ([@bib57]), a phosphoinositide phosphatase of the MTMR family ([@bib6]). Interestingly, Mtmr2 was previously described to be highly expressed in DRG sensory neurons and Schwann cells ([@bib6]). Functionally, Mtmr2 catalyzes the removal of a 3-phosphate group from its phosphoinositide (PIPs) substrates phosphatidylinositol 3-monophosphate PI(3)P and phosphatidylinositol 3,5-bisphosphate PI(3,5)P~2~ ([@bib1]; [@bib3]). Remarkably, PI(3,5)P~2~ is much less abundant than most other PIPs, for example PI(4,5)P~2~ ([@bib88]), but can be rapidly and transiently regulated by a large enzymatic protein complex in response to cellular stimulation ([@bib50]; [@bib78]; [@bib88]). Hence, PI(3,5)P~2~ is exquisitely suited to control rapid cellular signaling events ([@bib33]; [@bib36]; [@bib46]; [@bib50]; [@bib87]), and also the activity of receptors and ion channels ([@bib21]; [@bib33]; [@bib41]; [@bib50]; [@bib51]; [@bib77]). Altogether, this raises the question whether Mtmr2 and its PIP substrates are implicated in Piezo2-mediated mechanotransduction and generally, in somatosensory mechanosensation.

Here, we show that Mtmr2 levels control Piezo2-mediated RA-MA currents. While elevated Mtmr2 expression attenuated Piezo2 RA-MA currents, siRNA-mediated knockdown of Mtmr2 resulted in Piezo2 RA-MA current potentiation. Interestingly, heterologously expressed Piezo1 and other known subtypes of MA currents in DRG were largely unaffected. Mechanistically, our experiments with catalytically inactive Mtmr2, pharmacological inhibitors, and osmotic stress suggest that changes in the levels of PI(3,5)P~2~ regulate Piezo2 RA-MA currents. In line with these findings we uncovered a previously unknown polybasic motif in Piezo2 that can bind PI(3,5)P~2~ and confers Piezo2 sensitivity to Mtmr2. Collectively, our study reveals a link between Mtmr2 activity and PI(3,5)P~2~ availability to locally control Piezo2 function.

Results {#s2}
=======

Mtmr2 suppresses Piezo2-mediated RA-MA currents {#s2-1}
-----------------------------------------------

Our previous work revealed Mtmr2 as a highly enriched member of the native Piezo2 interactome in DRG (significance of identification: p=0.00030, unpaired t-test; enrichment factor: log~2~ 9.96) ([@bib57]). We first validated the reported expression of Mtmr2 in peripheral sensory neurons of DRG ([@bib65]; [@bib78]) including those neurons expressing Piezo2 ([Figure 1---figure supplement 1a,b](#fig1s1){ref-type="fig"}). For a more detailed subcellular analysis we used the proximity ligation assay (PLA). In this way we could show the close vicinity of Piezo2 and Mtmr2 in both, somata and neurites of cultured DRG neurons, and upon co-transfection in HEK293 cells ([Figure 1a--d](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1c,d](#fig1s1){ref-type="fig"}). It is important to note here that the PLA technique is prone to high background upon heterologous expression as shown by our additional control experiments in HEK293 cells ([Figure 1---figure supplement 1d](#fig1s1){ref-type="fig"}). In these, we co-overexpressed Piezo2 with TRPA1 and Vti1b, respectively. Both of these controls exhibited clear PLA signal (likely attributable to massive overexpression upon transfection), though less than co-overexpression with Mtmr2 ([Figure 1---figure supplement 1d](#fig1s1){ref-type="fig"}).

![Mtmr2 suppresses Piezo2-mediated RA-MA currents in HEK293 cells and DRG neurons.\
(**a--d**) Representative images (**a,c**) and quantification (**b,d**) of a proximity ligation assay (PLA) in cultured DRG neurons (**a,b**) of *Piezo2^GFP^* mice ([@bib83]) and HEK293 cells (**c,d**). As anti-Mtmr2 antibodies failed to work in neuronal cultures, DRG were transfected with Mtmr2-myc or mock-myc and PLA was performed with antibodies against Piezo2 and myc. Please note the distribution of the PLA signal in soma and neurites of DRG. HEK293 cells were co-transfected with Piezo2-GST-IRES-GFP and Mtmr2-myc or Piezo2-GST-IRES-GFP and mock-myc and PLA was performed with antibodies against GST and myc. Only cells with pronounced GFP signal (due to expression of pmaxGFPVector in DRG and Piezo2-GST-IRES-GFP in HEK293 cells) were considered for the analysis. Cell boundaries are demarcated in yellow. In both cell types, DRG and HEK293 cells, transfection of Mtmr2-myc exhibited significantly stronger PLA signal compared to controls (**b,d**). Scale bar: 10 µm. Quantification of the total area of PLA signal/total soma area (fraction of PLA-positive area) in DRG cultures (p\<0.0001; Mann-Whitney test; + mock: n = 53 neurons; + Mtmr2-myc: n = 53 neurons) (**b**). The quantification of the intensity of PLA signal in neurites of cultured DRG neurons can be found in [Figure 1---figure supplement 1c](#fig1s1){ref-type="fig"}. Quantification of the total area of PLA signal/total cell area in HEK293 cells (fraction of PLA-positive area) (p\<0.0001; Mann-Whitney test; Piezo2-GST + mock: n = 60 cells; Piezo2-GST + Mtmr2-myc: n = 54 cells) (**d**). Additional controls for PLA in HEK293 cells can be found in [Figure 1---figure supplement 1d](#fig1s1){ref-type="fig"}. (**e**) Representative traces of RA-MA currents in HEK293 cells upon co-expression of Piezo2 with mock or Mtmr2 and (**f**) stimulus-current curves. Overexpression of Mtmr2 suppressed Piezo2 current magnitudes compared to mock overexpression (Piezo2 + mock: n = 17 cells; Piezo2 + Mtmr2: n = 12 cells; 2-way ANOVA suggested a significant effect (P\<0.0001) of Mtmr2 overexpression on Piezo2 currents; Holm-Sidak's multiple comparisons test was used to compare both conditions at individual stimulus magnitudes, p-values are indicated by \* in the graph). The displacement threshold was increased upon co-expression of Mtmr2 (p=0.0098; Mann-Whitney test; [Supplementary file 1](#supp1){ref-type="supplementary-material"}). The inactivation time constant of RA-MA currents remained unchanged ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). (**g**) Representative traces of RA-MA currents in primary cultures of DRG neurons and (**h**) stimulus-current curves showed a significant decrease in RA-MA current magnitude upon overexpression of Mtmr2 compared to mock ( + mock: n = 28 neurons; + Mtmr2: n = 30 neurons; 2-way ANOVA suggested a significant effect (P\<0.0022) of Mtmr2 overexpression on RA-MA currents; Holm-Sidak's multiple comparison test was performed to compare both conditions at individual stimulus magnitudes, p-values are indicated by \* in the graph). The displacement threshold and inactivation time constant of RA-MA currents were not changed upon overexpression of Mtmr2 in DRG neurons ([Supplementary file 1](#supp1){ref-type="supplementary-material"}).](elife-32346-fig1){#fig1}

Following, we wanted to assess whether Mtmr2 affects Piezo2 function. To this end we performed electrophysiological measurements of Piezo2-mediated RA-MA currents in HEK293 cells, which represent a well-defined heterologous system to study Piezo2 function ([@bib16]; [@bib63]). Interestingly, Mtmr2 co-expression led to a pronounced reduction of Piezo2-mediated RA-MA currents compared to mock conditions ([Figure 1e,f](#fig1){ref-type="fig"}). Moreover, the displacement threshold of RA-MA currents was significantly increased upon Mtmr2 overexpression indicating the requirement of stronger mechanical stimulation to reach a threshold current amplitude ([Supplementary file 1](#supp1){ref-type="supplementary-material"}; please see Materials and methods for details on the calculation of the displacement threshold) ([@bib26]; [@bib56]; [@bib57]). Importantly, the inactivation time constant of Piezo2 currents remained unchanged upon Mtmr2 co-expression ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). These data indicate that Mtmr2 overexpression suppresses Piezo2 currents in HEK293 cells while maintaining their defining property, that is rapid adaptation. To exclude that Mtmr2 overexpression renders cells unhealthy and might therefore unspecifically suppress Piezo2 currents, we co-expressed Mtmr2 with Kv1.1 and measured voltage-gated currents, which were similar to mock transfected controls ([Figure 1---figure supplement 2a](#fig1s2){ref-type="fig"}). In addition, we asked whether Mtmr2 may modulate MA currents generated by Piezo1, the homologue of Piezo2 ([@bib16]). Remarkably, we did not observe any differences in Piezo1 currents upon overexpression of Mtmr2 ([Figure 1---figure supplement 2b](#fig1s2){ref-type="fig"} and [Supplementary file 1](#supp1){ref-type="supplementary-material"}). These results suggest a certain degree of specificity of the functional Piezo2-Mtmr2 interaction.

Next, we aimed at assessing whether Mtmr2 can modulate native Piezo2 RA-MA currents in cultured DRG neurons, as well. DRG cultures allow for the targeted manipulation of protein levels by nucleofection and concomitant assessment of Piezo2-mediated RA-MA currents ([@bib16]; [@bib57]). It is also noteworthy, that the DRG culture system has been employed for the original discovery ([@bib16]) and further characterization of Piezo2 RA-MA currents ([@bib25]; [@bib26]; [@bib38]; [@bib57]; [@bib63]; [@bib66]); hence it serves as a model for sensory transduction processes ([@bib15]; [@bib16]; [@bib43]).

In order to test whether the effect on Piezo2 RA-MA currents observed in HEK293 cells can be recapitulated, we overexpressed Mtmr2 in DRG cultures and measured RA-MA currents. Similar to HEK293 cells, Mtmr2 overexpression suppressed native RA-MA currents in DRG cultures when compared to mock transfection ([Figure 1g,h](#fig1){ref-type="fig"}). The displacement threshold was unaffected upon Mtmr2 overexpression ([Supplementary file 1](#supp1){ref-type="supplementary-material"}), which is in contrast to our results in HEK293 cells potentially reflecting differences in Piezo2/Mtmr2 stoichiometry or the contribution of unknown neuronal modulators. Also, the inactivation time constant of RA-MA currents was unchanged upon overexpression of Mtmr2 in DRG neurons ([Supplementary file 1](#supp1){ref-type="supplementary-material"}).

Mtmr2 knockdown potentiates Piezo2 activity in peripheral sensory neurons {#s2-2}
-------------------------------------------------------------------------

We went on to investigate whether Mtmr2 downregulation could potentiate native RA-MA currents in DRG. Successful knockdown of *Mtmr2* was achieved after 72 hr and evaluated by quantitative PCR ([Figure 2---figure supplement 1a](#fig2s1){ref-type="fig"}). We assessed *Piezo2* mRNA levels, Piezo2 membrane expression and the percentage of Piezo2-positive neurons and did not observe any changes upon Mtmr2 knockdown ([Figure 2---figure supplement 1b--d](#fig2s1){ref-type="fig"}). However, when we measured RA-MA currents in *Mtmr2* siRNA-nucleofected DRG cultures, we observed a significant augmentation in current amplitude whereas the displacement threshold and inactivation time constant were unchanged ([Figure 2a--b](#fig2){ref-type="fig"}; [Supplementary file 1](#supp1){ref-type="supplementary-material"}). These results are in agreement with our data on Mtmr2 overexpression ([Figure 1](#fig1){ref-type="fig"}) and suggest that Mtmr2 levels can modulate Piezo2 function: decreased expression of Mtmr2 potentiated, while increased expression suppressed Piezo2 RA-MA currents.

![Mtmr2 knockdown potentiates Piezo2 activity in peripheral sensory neurons.\
(**a**) Representative traces of RA-MA currents in primary cultures of DRG neurons and (**b**) stimulus-current curves for RA-MA currents upon nucleofection of *Mtmr2* siRNA showed a significant increase in RA-MA current magnitude compared to nucleofection with AllStar Negative Control siRNA (CTRL: n = 66 neurons; *Mtmr2* siRNA: n = 77 neurons; 2-way ANOVA suggested a pronounced effect (P\<0.0003) of Mtmr2 knockdown on RA-MA currents; Holm-Sidak's multiple comparisons test was used to compare both conditions at individual stimulus magnitudes, p-values are indicated by \* in the graph). The displacement threshold and inactivation time constant of RA-MA currents remained unchanged upon knockdown of Mtmr2 ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). Of note, MA current properties cannot be compared between different experiments or treatments of DRG cultures, for example [Figure 2b](#fig2){ref-type="fig"} cannot be compared to overexpression of Mtmr2 ([Figure 1](#fig1){ref-type="fig"}). Cultures were differently nucleofected (siRNA vs. plasmids) and recorded on different days in vitro (DIV) according to established protocols (please see Materials and methods for details). Hence matching controls were performed for each set of data. (**c**) Stimulus-current curves show IA-MA currents were unaffected by knockdown of Mtmr2 in DRG neurons (CTRL: n = 23 neurons; *Mtmr2* siRNA: n = 10 neurons; ns; 2-way ANOVA). (**d**) Stimulus-current curves show SA-MA currents were unchanged upon Mtmr2 knockdown (n = 11--12 neurons per condition; ns; 2-way ANOVA). Of note, the displacement thresholds and inactivation time constants of IA-MA and SA-MA currents remained unchanged upon *Mtmr2* siRNA nucleofection ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). (**e**) Stacked histograms show the number of cells exhibiting different MA currents upon knockdown of Mtmr2 in cultured DRG. The proportions of cells exhibiting RA and IA currents were significantly changed in cultures transfected with *Mtmr2* siRNA. RA:IA:SA:NR (% of total; rounded to whole numbers): CTRL: 46:16:9:29; *Mtmr2* siRNA: 58:7:12:23; p\<0.044 overall and for the proportion of RA/total (p=0.048) and IA/total (p=0.023), respectively; Chi-square test;≥130 neurons were analyzed per condition). NR (non-responsive), refers to cells which showed no MA current.](elife-32346-fig2){#fig2}

Besides Piezo2-mediated RA-MA currents, cultured DRG neurons display two other major types of MA currents: intermediately- (IA) and slowly-adapting- (SA) MA currents categorized based on their inactivation time constant (please see Materials and methods for details) ([@bib15]; [@bib16]; [@bib35]; [@bib43]). These seemed to be largely unaltered by Mtmr2 knockdown ([Figure 2c,d](#fig2){ref-type="fig"}; [Supplementary file 1](#supp1){ref-type="supplementary-material"}) indicating that mechanotransduction is not generally compromised. Remarkably though, upon Mtmr2 knockdown we detected a significant redistribution of the number of cells exhibiting MA subpopulations: a moderate increase in the proportion of RA-MA cells paralleled by a decrease of the IA-MA population ([Figure 2e](#fig2){ref-type="fig"}). To date the interpretation of the latter is difficult and requires yet to be obtained insights into the molecular nature of IA-MA currents.

Mtmr2 modulates Piezo2-mediated mechanotransduction largely via PI(3,5)P~2~ {#s2-3}
---------------------------------------------------------------------------

Next we asked how, on a mechanistic level, Mtmr2 could regulate Piezo2 activity given that neither Piezo2 mRNA levels nor membrane expression seemed to be affected ([Figure 2---figure supplement 1b,c](#fig2s1){ref-type="fig"}). Mtmr2 is a phosphatase that catalyzes the removal of the 3-phosphate group from PI(3)P as well as PI(3,5)P~2~ ([@bib3]). Under resting conditions PI(3,5)P~2~ is present at low levels ([@bib39]; [@bib50]) but is transiently and steeply generated upon a diverse range of cellular stressors. This is in contrast to intensely studied and highly abundant PI(4,5)P~2~ known to regulate ion channels ([@bib28]) including both, Piezo1 and Piezo2 ([@bib10]).

To explore a potential role of Mtmr2 phosphatase activity and the resulting change in PIP levels ([@bib42]; [@bib51]; [@bib54]; [@bib64]) for the regulation of Piezo2 currents, we generated a catalytically inactive Mtmr2 mutant (Mtmr2C417S) by substituting Cysteine 417 for Serine ([@bib3]). If the catalysis of PIPs was essential to the functional interaction of Piezo2-Mtmr2, the catalytically inactive mutant should fail to suppress Piezo2 currents when overexpressed in HEK293 cells (please see our data on wild type Mtmr2 in [Figure 1e,f](#fig1){ref-type="fig"}). This was indeed found to be the case. Mtmr2C417S co-expression did not suppress Piezo2-mediated currents in HEK293 cells as determined by comparison of stimulus-current curves ([Figure 3a](#fig3){ref-type="fig"}) with mock transfected cells. Instead, we observed a trend towards moderate potentiation of Piezo2 currents upon co-expression of Mtmr2C417S (especially at low stimulus magnitudes; [Figure 3a](#fig3){ref-type="fig"}). This result strongly suggests that the catalytic activity of Mtmr2 and the consequential alteration of PIP levels ([@bib42]; [@bib51]; [@bib54]; [@bib64]) may underlie the regulation of Piezo2 by Mtmr2. Importantly, enzymatically inactive Mtmr2C417S was abundantly expressed and remained capable of associating with Piezo2 in close proximity as suggested by PLA upon co-overexpression of Piezo2 and Mtmr2C417S in comparison to wild type Mtmr2 ([Figure 3b--c](#fig3){ref-type="fig"}).

![Catalytic activity of Mtmr2 is necessary to suppress Piezo2-mediated RA-MA currents.\
(**a**) Stimulus-current curves upon co-expression of Piezo2 with the catalytically inactive Mtmr2 C417S mutant in HEK293 cells compared to mock controls. Mtmr2 C417S overexpression slightly, but not significantly increased Piezo2 RA-MA currents especially at lower stimulus magnitudes (Piezo2 + mock: n = 17 cells; Piezo2 + Mtmr2 C417S: n = 18 cells). 2-way ANOVA reported a significant (P\<0.0021) overall effect of Mtmr2 C417S overexpression on RA-MA currents, however a Holm-Sidak's multiple comparisons test showed no significant difference between currents at individual stimulus magnitudes.). Of note, the displacement thresholds and inactivation time constant were unaffected upon overexpression with Mtmr2 C417S compared to mock ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). (**b--c**) Representative images (**b**) and quantification (**c**) of PLA signal using antibodies against GST and myc to detect Piezo2-GST-IRES-GFP and Mtmr2 C417S-myc, respectively. PLA signal upon co-transfection of Piezo2-GST + Mtmr2 C417S-myc was indistinguishable from Piezo2-GST + Mtmr2 myc and significantly stronger than Piezo2-GST + mock. Cell boundaries are demarcated in yellow. Only cells with pronounced GFP signal (due to expression of Piezo2-GST-IRES-GFP) were considered for the analysis. Scale bar: 10 µm. Quantification of the number of the total area of PLA signal/total cell area (fraction of PLA-positive area) (**c**); p\<0.0001 compared to Piezo2-GST + mock, Kruskal-Wallis test followed by Dunn's Multiple Comparison Test; Piezo2-GST + mock: n = 75 cells; Piezo2-GST + Mtmr2-myc: n = 70 cells; Piezo2-GST + Mtmr2 C417S-myc: n = 70 cells.](elife-32346-fig3){#fig3}

Based on the results obtained from experiments with Mtmr2C417S we then proceeded to manipulate neuronal PIP levels. [Figure 4a](#fig4){ref-type="fig"} illustrates a schematic view of the PIP synthesis and turnover pathway Mtmr2 is involved in and also indicates pharmacological inhibitors known to intervene with this pathway ([@bib78]). According to this scheme and a wealth of previous work ([@bib42]; [@bib51]; [@bib54]; [@bib64]; [@bib78]), knockdown of Mtmr2 would increase the levels of PI(3)P and even more PI(3,5)P~2~ ([@bib78]). We tried to experimentally mimic heightened levels of these PIPs by inclusion of exogenous PIPs in the intracellular recording solution ([@bib21]); however, we did not see any change in RA-MA currents ([Figure 4---figure supplement 1a](#fig4s1){ref-type="fig"}). Due to technical factors that may confound this data (e.g. rapid breakdown of exogenous PIPs by intracellular phosphatases), we opted to perform additional experiments. We reversed the described accumulation of these two PIPs upon Mtmr2 knockdown ([@bib42]; [@bib51]; [@bib54]; [@bib64]; [@bib78]) by applying commonly-used inhibitors of PIP synthesis, that is Wortmannin, an inhibitor of the class III PI 3-kinase, ([@bib53]), and Apilimod, an inhibitor of PIKfyve ([@bib13]; [@bib78]), respectively (please see scheme in [Figure 4a](#fig4){ref-type="fig"}). If elevated levels of PI(3)P or PI(3,5)P~2~ were implicated in Mtmr2-knockdown-induced potentiation of Piezo2, the presence of the corresponding inhibitor in the recording solution would be expected to counteract this potentiation. Wortmannin application only marginally altered the increase in RA-MA currents upon Mtmr2 knockdown in neurons ([Figure 4b](#fig4){ref-type="fig"}). Apilimod, on the other hand, significantly diminished the magnitude of RA-MA currents in *Mtmr2* siRNA-treated neurons ([Figure 4b](#fig4){ref-type="fig"}). In line with a reversal of Mtmr2-induced potentiation, the displacement threshold of RA-MA currents was significantly increased upon Apilimod treatment ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). Interestingly, Apilimod treatment in wild type DRG neurons did not affect RA-MA currents ([Figure 4---figure supplement 1b](#fig4s1){ref-type="fig"}; [Supplementary file 1](#supp1){ref-type="supplementary-material"}), as expected given the low cellular expression and tight regulation of PI(3,5)P~2~ under physiological conditions ([@bib39]; [@bib50]). Taken together, our results point towards a role of PI(3,5)P~2~ for the functional interaction of Piezo2 and Mtmr2.

![Mtmr2 modulates Piezo2-mediated RA-MA currents mainly via PI(3,5)P~2~.\
(**a**) Scheme illustrating the major steps of PI(3,5)P~2~ synthesis and turnover including commonly used inhibitors and their targets. Wortmannin is an inhibitor of the phosphatidylinositol 3-kinase (PI3-Kinase) while Apilimod inhibits phosphatidylinositol 3-phosphate 5-kinase (PIKfyve). The *Fig4* gene encodes a polyphosphoinositide phosphatase. (**b**) Stimulus-current curves after addition of Wortmannin, Apilimod or vehicle (DMSO) to *Mtmr2* siRNA-treated neurons (*Mtmr2* siRNA + DMSO: n = 27 neurons; *Mtmr2* siRNA + Wortmannin: n = 28 neurons; *Mtmr2* siRNA + Apilimod: n = 30 neurons). 2-way ANOVA suggested a significant (P\<0.0007) overall effect on RA-MA currents. Holm-Sidak's multiple comparisons test was performed to compare both conditions to DMSO at individual stimulus magnitudes. While no significant difference between Wortmannin and DMSO at individual stimulus magnitudes was observed, Apilimod application showed a significant reduction of currents compared to DMSO, p-values are indicated by \* in the graph. Similarly, only Apilimod treatment increased the displacement threshold (p=0.0055 compared to DMSO-treated neurons, Kruskal-Wallis test followed by Dunn´s multiple comparisons test; [Supplementary file 1](#supp1){ref-type="supplementary-material"}). The inactivation time constants were unaltered by either treatment ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). (**c**) Hypotonic extracellular solution counteracted the inhibition of Piezo2 RA-MA currents caused by Mtmr2 overexpression. Stimulus-current curves for Piezo2 RA-MA currents upon extracellular hypotonic stress application to DRG neurons overexpressing Mtmr2 (Mtmr2 + Isotonic extracellular solution: n = 14 neurons; Mtmr2 + Hypotonic extracellular solution: n = 19 neurons; 2-way ANOVA suggested that extracellular hypotonic stress had a significant (P\<0.0001) effect on RA-MA currents. Holm-Sidak's multiple comparisons test was performed to compare both conditions at individual stimulus magnitudes, p-values are indicated by \* in the graph. The displacement threshold of RA-MA currents and inactivation time constant of RA-MA currents were unchanged ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). (**d**) Hypotonic intracellular solution counteracted the potentiation of Piezo2 RA-MA currents caused by Mtmr2 knockdown. Stimulus-current curves for Piezo2 RA-MA currents upon intracellular hypotonic stress application to DRG neurons treated with *Mtmr2* siRNA (*Mtmr2* siRNA + Isotonic intracellular solution: n = 29 neurons; *Mtmr2* siRNA + Hypotonic intracellular solution: n = 25 neurons; 2-way ANOVA suggested that intracellular hypotonic stress had a significant (P\<0.0001) effect on RA-MA currents. Holm-Sidak's multiple comparisons test was performed to compare both conditions at individual stimulus magnitudes, p-values are indicated by \* in the graph. The displacement threshold of RA-MA currents was increased upon intracellular hypotonic stress (p=0.0131; Mann-Whitney test; [Supplementary file 1](#supp1){ref-type="supplementary-material"}). The inactivation time constant of RA-MA currents was unchanged ([Supplementary file 1](#supp1){ref-type="supplementary-material"}).](elife-32346-fig4){#fig4}

We then intended to assess the significance of PI(3,5)P~2~ availability for Piezo2 function in a more physiological setting. In peripheral sensory neurons changes in cellular osmolarity cause activation of diverse ion channels and receptors followed by initiation of various signaling pathways involved in volume regulation ([@bib44]; [@bib48]; [@bib67]). Interestingly, previous work has indicated that also Mtmr2, PI(3,5)P~2~ ([@bib4]; [@bib22]) and Piezo2 ([@bib38]) can be modulated by osmotic stress. Upon hypoosmotic stress Mtmr2 trafficking was altered and PI(3,5)P~2~ levels were reported to be elevated in eukaryotic cells ([@bib4]; [@bib22]). In the case of Piezo2, hypoosmotic stress was shown to potentiate Piezo2 RA-MA currents, which was independent of the prominent osmosensor TRPV4 ([@bib38]). Therefore, we employed osmotic stress as a physiological stimulus to investigate the link between Mtmr2, PI(3,5)P~2~ and Piezo2. First, we confirmed the previously described ([@bib38]) potentiation of Piezo2 RA-MA currents by application of extracellular hypotonic stress to DRG cultures ([Figure 4---figure supplement 1c](#fig4s1){ref-type="fig"}). We then postulated that an increase of PI(3,5)P~2~ levels by extracellular hypotonicity ([@bib4]; [@bib22]) should counteract the RA-MA suppression upon Mtmr2-overexpression, which we described in [Figure 1h](#fig1){ref-type="fig"} above. Indeed, in Mtmr2 overexpressing DRG cultures we recorded significantly higher RA-MA currents under extracellular hypotonic conditions compared to isotonic conditions ([Figure 4c](#fig4){ref-type="fig"}). Other RA-MA current parameters were unchanged ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). We then tested whether the opposite was also true: Would an expected decrease of PI(3,5)P~2~ levels by intracellular hypotonicity ([@bib22]) prevent RA-MA current sensitization upon Mtmr2 knockdown? Conceptually, this experiment is analogous to Apilimod application in [Figure 4b](#fig4){ref-type="fig"} above, where we pharmacologically inhibited PI(3,5)P~2~ production in DRG cultures. As predicted, under intracellular hypotonic conditions RA-MA currents were significantly smaller in siRNA-treated cultures compared to isotonic conditions ([Figure 4d](#fig4){ref-type="fig"}; [Supplementary file 1](#supp1){ref-type="supplementary-material"}). In parallel, the displacement threshold was significantly increased, while other RA-MA current parameters remained unchanged ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). As specific probes to assess the cellular distribution of PI(3,5)P~2~ are not available ([@bib31]; [@bib47]; [@bib50]; [@bib60]; [@bib64]), we could not measure the actual levels of PI(3,5)P~2~ in neurons under different osmotic conditions. Even though, our pharmacological and osmotic experiments both suggest an interdependent contribution of Mtmr2 and PI(3,5)P~2~ to the modulation of Piezo2-mediated MA currents in DRG cultures.

PIPs are essential membrane components and alterations of PIP availability could modify mechanical properties of cells and their membranes ([@bib37]; [@bib69]; [@bib74]). In fact, several recent studies demonstrated the influence of membrane mechanics on mechanotransduction ([@bib11]; [@bib12]; [@bib19]; [@bib45]; [@bib75]; [@bib84]), particularly on Piezo2-mediated RA-MA currents ([@bib38]; [@bib66]). Therefore, we set out to test a possible impact of Mtmr2 knockdown upon mechanical properties of cultured DRG neurons by atomic force microscopy (AFM) ([@bib58]; [@bib66]; [@bib70]). However, our experiments did not show any significant differences between *Mtmr2* siRNA-treated and control-treated DRG neurons. Neither the Young´s elastic modulus (an indicator for cellular elasticity including membrane tension and cortex stiffness) ([@bib56]; [@bib66]) as determined from the indentation, nor the tether force (an indicator for membrane tension and mechanical coupling to the cortex) ([@bib66]) obtained from the retraction portion of the force distance curves were altered ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). These results are in line with our aforementioned findings indicating that Mtmr2 knockdown does not fundamentally alter mechanotransduction in DRG cultures ([Figure 2c,d](#fig2){ref-type="fig"} and [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Nevertheless, our AFM measurements cannot exclude possible small and local changes in membrane tension in the direct vicinity of Piezo2.

Piezo2 harbors a PIP~2~ binding motif {#s2-4}
-------------------------------------

Based on the functional role of PI(3,5)P~2~ for Mtmr2-dependent Piezo2 regulation we investigated whether Piezo2 can bind PI(3,5)P~2~. PIPs are known to bind to proteins through various domains such as the FYVE domain, WD40 domain, PHD domain or electrostatically via poly-basic regions with unstructured clusters of positively charged amino acid residues (Lysine or Arginine) ([@bib21]; [@bib50]). Sequence analysis revealed a region in Piezo2 with considerable similarity to the proposed PI(3,5)P~2~ binding motif of the mucolipin TRP channel 1 (TRPML1) ([@bib21]) ([Figure 5a](#fig5){ref-type="fig"}). We performed a peptide-lipid binding assay to test if this sequence in Piezo2 could bind to PI(3,5)P~2~, which was indeed the case ([Figure 5b,d](#fig5){ref-type="fig"}). In addition, we also observed that the Piezo2 peptide was able to bind PI(4,5)P~2~ and weakly to PI(3,4)P~2~ ([Figure 5b,d](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). This is an intriguing result because Borbiro and colleagues showed that TRPV1 modulates Piezo2 currents through PI(4,5)P~2~ depletion, though the study did not report a PI(4,5)P~2~ binding region in the Piezo2 sequence ([@bib10]). In parallel we performed the binding assay with a mutated version of the Piezo2 peptide, in which positively-charged amino acid residues shown to be relevant for PI(3,5)P~2~ binding in TRPML1 were changed to neutral Glutamine (Q; Piezo2 3Q mutant; QQILQYFWMS). This mutated peptide did not bind to any lipid ([Figure 5b,d](#fig5){ref-type="fig"}). The here identified PI(3,5)P~2~-binding region in Piezo2 exhibits 50% sequence identity to Piezo1 with conservation of positively charged amino acid residues ([Figure 5a](#fig5){ref-type="fig"}). Therefore, we also tested whether Piezo1 was able to bind PI(3,5)P~2~, but did not find any evidence for this ([Figure 5c,d](#fig5){ref-type="fig"}). These data suggest that not only positively charged amino acid residues, but also flanking amino acids in this Piezo2 region contribute to PIP~2~ binding in a yet to be explored manner. Further, these in vitro binding studies substantiate our functional data on the specific link between Piezo2 and the Mtmr2 substrate PI(3,5)P~2~ by identifying a PI(3,5)P~2~ binding domain in Piezo2, but not in Piezo1. It is important to note that the peptide region defined here may not be the only PI(3,5)P~2~ binding region in Piezo2 especially when considering the known diversity of PIP modules ([@bib21]; [@bib50]). Due to the sheer size of Piezo2 a large-scale peptide-lipid binding screen was beyond the scope of this study.

![Murine Piezo2, but not Piezo1, harbors a PIP~2~ binding motif.\
(**a**) Schematic view of the PI(3,5)P~2~ binding region of TRPML1 identified elsewhere ([@bib21]) and the region in murine Piezo2 that exhibits pronounced sequence similarity to the PI(3,5)P~2~ binding region of TRPML1. The indicated sequences were used to generate peptides for Piezo2, the Piezo2 3Q mutant and Piezo1. All peptides were tagged with a FLAG-epitope to allow for detection with anti-Flag antibodies on immunoblots. (**b--d**) Representative peptide-lipid binding assays followed by immunoblotting after incubation with indicated peptides (**b, c**) and densitometric quantification (**d**). The arrangement of lipids on the lipid-strip is indicated; blank, no lipid was spotted. The Piezo2 peptide strongly binds to PI(3,5)P~2~ and PI(4,5)P~2~, and weakly to PI(3,4)P~2~. Neither the Piezo2 3Q mutant peptide nor the Piezo1 peptide exhibited significant binding to any of the lipids tested. One-way ANOVA followed by Dunnett's multiple comparisons test was used to compare spot signal densities for each peptide to the respective blank, p-values are indicated by \# in the graph (**d**). In addition, one-way ANOVA followed by Holm-Sidak's multiple comparisons test was used to compare spot signal densities across the three peptides, p-values are indicated by \* in the graph (**d**). The graph only presents data for those lipids, to which the Piezo2 peptide exhibited significant binding. Please see [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} for summarized data on lipids tested with the Piezo2 peptide. Experiments using the Piezo2 peptides were independently repeated 6 times, of which four times were conducted in parallel with experiments using the Piezo1 peptide. AU, arbitrary units. (**e**) Stimulus-current curves upon co-expression of the Piezo2 P1 mutant with Mtmr2 in HEK293 cells compared to mock controls. Mtmr2 only slightly attenuated MA currents (Piezo2 P1 mutant + mock: n = 13 cells; Piezo2 P1 mutant + Mtmr2: n = 10 cells). 2-way ANOVA reported a significant (P\<0.0119) overall effect of Mtmr2 overexpression on RA-MA currents of the Piezo2 P1 mutant, however a Holm-Sidak's multiple comparisons test showed no significant difference between currents at individual stimulus magnitudes. Of note, the displacement threshold and inactivation time constant were also unaffected upon overexpression of Mtmr2 compared to mock ([Supplementary file 1](#supp1){ref-type="supplementary-material"}).](elife-32346-fig5){#fig5}

Next, we attempted to monitor the functional relevance of the here described PI(3,5)P~2~ binding domain for the Piezo2-Mtmr2 interaction. To this end we generated a Piezo2 P1 mutant by swapping the PI(3,5)P~2~ binding domain of Piezo2 with the corresponding domain of Piezo1 (please see scheme in [Figure 5a](#fig5){ref-type="fig"}). Remarkably, MA currents of the Piezo2 P1 mutant were only slightly attenuated upon co-expression with Mtmr2 compared to mock-transfected controls ([Figure 5e](#fig5){ref-type="fig"}). Also, the displacement threshold and inactivation time constant of MA currents remained unchanged ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). This is in stark contrast to the pronounced Mtmr2-induced suppression of MA currents recorded from wildtype Piezo2 ([Figure 1f](#fig1){ref-type="fig"}). Hence, our results suggest that the PI(3,5)P~2~ binding domain of Piezo2 identified here likely mediates the functional sensitivity of Piezo2 to Mtmr2-dependent changes in PI(3,5)P~2~ levels.

Discussion {#s3}
==========

Vertebrate somatosensory mechanotransduction entails a complex interplay of cellular components; however, their identity is far from being resolved. In our study, we demonstrate that Mtmr2 limits Piezo2 MA currents, and that this effect likely involves local catalysis of PI(3,5)P~2~. Thus, our work elucidated a link between Mtmr2 and PI(3,5)P~2~ availability as a previously unappreciated mechanism how Piezo2-mediated mechanotransduction can be locally controlled in peripheral sensory neurons.

Originally, we identified Mtmr2 as a significantly enriched member of the native Piezo2 interactome in DRG neurons ([@bib57]). Mtmr2 is an active phosphatase that catalyzes the removal of 3-phosphate from its substrates PI(3)P and PI(3,5)P~2~. Hence, its subcellular localization is crucial as it dictates access to its substrates, which are embedded in membrane lipid bilayers. Interestingly, several reports suggest that membrane association of Mtmr2 is enhanced by hypotonic stress ([@bib4]) and also by interactions with other members of the Mtmr family ([@bib40]; [@bib59]). For example, Mtmr13 and Mtmr2 reciprocally control their abundance at the membrane of cultured cell lines ([@bib59]; [@bib71]) and in uncharacterized endomembrane compartments in Schwann cells ([@bib59]). In addition, Mtmr2 enzymatic activity is augmented through interaction with Mtmr13 ([@bib2]). In this respect it is noteworthy that our interactomics screen ([@bib57]) identified two additional Mtmr family members: Mtmr1 and Mtmr5. Mtmr1 was shown to be similar to Mtmr2 in structure and substrate specificity ([@bib8]), but is much less studied than Mtmr2. Mtmr5 is a catalytically inactive phosphatase which binds to Mtmr2, increases its enzymatic activity and controls its subcellular localization ([@bib40]). The fact that Mtmr5 was previously reported as a binding partner of Mtmr2 further validates our published interactomics data ([@bib57]), and hints towards the intriguing possibility that a multiprotein complex of different Mtmr family members might affect Piezo2 function. Future experiments should focus on assessing the role of these two Mtmr family members for mechanotransduction in peripheral sensory neurons.

Mechanistically, our in vitro data strongly suggest that enzymatic activity of Mtmr2 and consequently PI(3,5)P~2~ availability modulates Piezo2 RA-MA currents. Several lines of evidence support this conclusion. We found that, unlike wild type Mtmr2, a catalytically inactive mutant of Mtmr2 (C417S) did not suppress Piezo2 currents in HEK293 cells. In sensory neurons expressing *Mtmr2* siRNA, we could counteract RA-MA current potentiation by inhibiting PI(3,5)P~2~ synthesis in two ways: via Apilimod ([@bib42]; [@bib51]; [@bib54]; [@bib64]; [@bib78]) and via intracellular hypoosmolarity ([@bib22]; [@bib50]), respectively. In analogy, increasing PI(3,5)P~2~ levels by extracellular hypoosmolarity ([@bib4]; [@bib22]) attenuated the suppression of RA-MA currents upon Mtmr2 overexpression. Here, it is important to note that Mtmr2 activity usually serves a dual function: dephosphorylation of PI(3,5)P~2~ and of PI(3)P, albeit the latter with lower efficiency ([@bib3]). Yet, our results upon application of Wortmannin suggest only a marginal contribution of PI(3)P to altering Piezo2-mediated mechanotransduction. Wortmannin is commonly used to block class III PI 3-kinase (please see scheme in [Figure 4a](#fig4){ref-type="fig"}), however, it also is reported to inhibit class I PI 3-kinase ([@bib53]). Hence its action on class III PI 3-kinase might not have been efficient enough in our experiments. Biologically, many enzymes control PI(3)P synthesis ([@bib86]; [@bib88]) and previous work on Mtmr2 has only shown minor modifications of PI(3)P levels in Mtmr2-deficient cells ([@bib14]; [@bib78]) in line with its substrate preference ([@bib3]). Moreover, our lipid-peptide binding assays demonstrated that, in a cell-free system, a distinct region in Piezo2, which is similar to the known PI(3,5)P~2~-binding motif of TRPML1, can bind PI(3,5)P~2~. Therefore, our data are highly indicative of a prominent involvement of the Mtmr2 substrate PI(3,5)P~2~ in controlling somatosensory mechanosensitivity. Whether or not the expected change of PI(5)P after PI(3,5)P~2~ catalysis (please see scheme in [Figure 4a](#fig4){ref-type="fig"}) plays a role could not be investigated due to the lack of tools and knowledge about PI(5)P-specific physiology ([@bib50]; [@bib88]).

Interestingly, the here identified PI(3,5)P~2~-binding region is conserved among Piezo2 in vertebrates and exhibits 50% of sequence identity to mouse Piezo1 with conservation of basic amino acid residues. Arthropods and nematodes, which only encode one Piezo protein, exhibit lower sequence similarity in this region, 40% (D. melanogaster) and 30% (C. elegans), respectively. It would be of high interest to determine in future studies whether other members of the Piezo family also bind PI(3,5)P~2~ and are potentially regulated by Mtmr2 or its homologs. Yet, in mice the here described PI(3,5)P~2~-binding and inhibition via Mtmr2 seemed quite specific for Piezo2 as indicated by our peptide-lipid binding assays and functional experiments on the domain-swapped Piezo2 P1 mutant. In contrast to the majority of studies on the regulation of vertebrate mechanotransduction ([@bib10]; [@bib26]; [@bib56]; [@bib63]; [@bib66]), we did not observe alterations in Piezo1-mediated MA currents in HEK293 cells, and the magnitude of IA- and SA-MA currents was largely unaffected in DRG cultures. Surprisingly though, we detected a mild increase in the proportion of RA-MA cells paralleled by a decrease of the IA-MA subpopulation. While there is some evidence that Piezo2 might also play a role for IA-MA currents ([@bib49]), to date the molecular identity of IA-MA currents has not been resolved ([@bib80]). For that reason the interpretation of this finding awaits further clarification of the molecular nature of IA-MA currents.

In principle, the regulation of Piezo2 by lipids is not unexpected and our data significantly advance our knowledge about the link between mechanotransduction and components of the lipid bilayer ([@bib11], [@bib12]; [@bib19]; [@bib45]; [@bib75]; [@bib84]). In particular, PI(4,5)P~2~ and its precursor PI(4)P ([@bib10]) as well as cholesterol ([@bib66]) were recently found to be implicated in mechanotransduction mediated by both, Piezo1 and Piezo2. In contrast to PI(4,5)P~2~, our understanding of PI(3,5)P~2~ function, localization and regulation is limited to date ([@bib50]). PI(3,5)P~2~ is much less abundant than most PIPs, for example 125-fold less than PI(4,5)P~2~ in mammalian cells ([@bib88]), and tightly regulated by a large protein complex ([@bib78]; [@bib88]) (please see scheme in [Figure 4a](#fig4){ref-type="fig"}). PI(3,5)P~2~ was believed to predominantly act in the endo-lysosome system of eukaryotes ([@bib20]; [@bib21]; [@bib33]; [@bib88]). By now the picture is emerging that PI(3,5)P~2~ can serve a diverse range of cellular functions, such as autophagy, signaling in response to stress, control of membrane traffic to the plasma membrane as well as regulation of receptors and ion channels ([@bib21]; [@bib33]; [@bib36]; [@bib41]; [@bib51]; [@bib77]; [@bib87]). Moreover, depending on the cell type, PI(3,5)P~2~ synthesis and metabolism are dynamically regulated and subject to cellular stimulation and stressors, for example insulin-mediated PI(3,5)P~2~ changes in adipocytes ([@bib36]), neuronal activity-dependent synthesis at hippocampal synapses ([@bib51]; [@bib87]) and the here exploited regulation of PI(3,5)P~2~ upon osmotic shock in mammalian cell lines ([@bib22]; [@bib60]; [@bib64]).

These reports nourish the notion that changes of PI(3,5)P~2~ via Mtmr2 might contribute to regulating Piezo2 and, by extension, touch sensitivity. How could this be achieved mechanistically? Instead of acting in a cell-wide manner, PI(3,5)P~2~ synthesis and turnover is confined to membrane microdomains. Despite their unknown composition and subcellular localization, these microdomains are believed to ensure dynamic and local control of PI(3,5)P~2~ levels ([@bib33]; [@bib39]; [@bib50]). Concomitantly, the abundance of downstream effector proteins is likely to be altered, as well ([@bib33]; [@bib39]; [@bib50]). Mtmr2 may physically bind to Piezo2 in order to ensure its enrichment in PI(3,5)P~2~ microdomains, so that local PI(3,5)P~2~ changes or yet to be identified effector proteins can efficiently modulate Piezo2 ([Figure 6](#fig6){ref-type="fig"}, working model). In these microdomains Mtmr2 would catalytically decrease PI(3,5)P~2~ levels, which in turn could inhibit Piezo2 function. Hence, a physical interaction between Mtmr2 and Piezo2 would selectively concentrate Piezo2 at the sites of PI(3,5)P~2~ depletion thereby allowing its inhibition in a defined membrane compartment. On the contrary, reduced Mtmr2 expression or activity would be expected to increase local PI(3,5)P~2~ levels ([@bib42]; [@bib51]; [@bib54]; [@bib64]; [@bib78]) and facilitate Piezo2 potentiation. It is conceivable that Mtmr2-controlled PI(3,5)P~2~ availability could in turn cause local changes in membrane tension ([@bib45]; [@bib62]; [@bib79]; [@bib85]). The latter has already been demonstrated to affect Piezo1 MA currents ([@bib19]; [@bib45]; [@bib84]). Whether Piezo2 is also sensitive to local membrane tension and whether PI(3,5)P~2~ levels indeed influence membrane tension in sensory neurons remains to be investigated. Unfortunately, local changes in membrane tension in the vicinity of Piezo2 are likely too small to be captured by our AFM-based measurements.

![Working model: Local control of Piezo2 function by interdependent actions of Mtmr2 and PI(3,5)P~2~.\
Mtmr2 controls the abundance of PI(3,5)P~2~ by dephosphorylation (please see [Figure 4a](#fig4){ref-type="fig"}). Mtmr2 and Piezo2 expression as well as PI(3,5)P~2~ might be compartmentalized in membrane microdomains. Piezo2 localization in Mtmr2-negative microdomains would facilitate its access to local PI(3,5)P~2~ and consequently potentiate Piezo2 RA-MA currents (left side). On the other hand, high Mtmr2 levels and its localization in the proximity of Piezo2 would augment PI(3,5)P~2~ turnover, thereby decreasing local PI(3,5)P~2~ availability and suppressing Piezo2 RA-MA currents (right side). One could further speculate that Mtmr2, via binding Piezo2, might recruit Piezo2 to membrane microdomains depleted of PI(3,5)P~2~. This would provide an active mechanism to inhibit Piezo2 RA-MA currents in membrane compartments -- may they be at the plasma membrane or intracellular membranes. Ultimately, Mtmr2 and PI(3,5)P~2~ may contribute to dynamically tuning touch sensitivity of an organism in response to diverse conditions modulating Mtmr2 and PI(3,5)P~2~ levels (e.g. osmotic stress as indicated by results shown in [Figure 4](#fig4){ref-type="fig"}).The following questions await further clarification: (i) How are Mtmr2/PI(3,5)P~2~ regulated during (patho)physiological conditions in the somatosensory system, (ii) does the modulation of RA-MA currents require additional yet to be identified effector proteins, and (iii) are other PIPs also involved, for example PI(4,5)P~2~ shown to modulate Piezo2 function ([@bib10])? As the structure of Piezo2 has not been resolved yet, Piezo2 is depicted after the recently solved structure of Piezo1 ([@bib29]; [@bib30]; [@bib72]). If this structure holds also true for Piezo2, the PI(3,5)P~2~ binding domain (depicted in green) would roughly be localized within the first third of the N-terminal blade.](elife-32346-fig6){#fig6}

Nevertheless, the data presented here allow us to infer an attractive mechanism exquisitely suited for transient and compartmentalized control of Piezo2 function, that is physical vicinity to Mtmr2, the activity status of Mtmr2 and consequently PI(3,5)P~2~ availability ([Figure 6](#fig6){ref-type="fig"}). We can further speculate that this local control of Piezo2 function may serve to tune the threshold and magnitude of neuronal activity to light touch. Ultimately, Mtmr2 and PI(3,5)P~2~ may represent a means by which touch sensitivity of an organism can be dynamically adjusted in response to diverse stimuli modulating Mtmr2 and PI(3,5)P~2~ levels ([Figure 6](#fig6){ref-type="fig"}). In this respect it is noteworthy that multiple Mtmr2 mutations -- including those affecting its activity ([@bib3]) -- have been implicated in Charcot-Marie-Tooth type 4B1 (CMT4B1) disease, a peripheral neuropathy characterized by abnormalities in myelination and nerve conduction ([@bib5]; [@bib7]; [@bib9]). An analysis of Piezo2 mechanotransduction, light touch as well as tactile hypersensitivity in Mtmr2 knockout ([@bib5]) and Mtmr2 mutant mice ([@bib9]) would be warranted to thoroughly examine the potential role of Mtmr2 for (patho)physiological aspects of vertebrate mechanosensation.

Several important questions remain to be investigated. While we identified a PI(3,5)P~2~ binding motif in Piezo2 in vitro, we can neither gauge the affinity of the fully assembled Piezo2 trimer for PI(3,5)P~2~ nor assess whether PI(3,5)P~2~ and Mtmr2 bind allosterically, competitively or independently of each other. Moreover, our peptide-lipid binding assay shows that the extremely abundant PI(4,5)P~2~ and to a lesser extent PI(3,4)P~2~ could bind the same motif as PI(3,5)P~2~. This raises the question how PIP~2~ specificity can be achieved by Piezo2 when embedded in cellular membranes. Piezo2 might be differentially localized in membranes dependent on PI(3,5)P~2~ levels and Mtmr2 abundance. We did not observe any differences in the overall abundance of Piezo2 channels at the plasma membrane of sensory neurons. Yet, given that PI(3,5)P~2~ acts in membrane microdomains, it would be desirable to visualize whether Piezo2 is localized in subcellular membrane compartments, that is (i) in PI(3,5)P~2~-enriched versus PI(3,5)P~2~-depleted and/or (ii) Mtmr2-harboring versus Mtmr2-negative microdomains. It remains to be seen whether these membrane compartments are confined to the plasma membrane and/or to intracellular membranes such as endo-lysosomes, which are known to contain the majority of PI(3,5)P~2~ ([@bib20]; [@bib21]; [@bib88]). Along these lines it is worth mentioning that AMPA receptor abundance at hippocampal synapses has been shown to be regulated by PI(3,5)P~2~-controlled cycling through early and late endosomes ([@bib51]). While unknown so far, localization of Piezo2 to intracellular membranes would not be unexpected ([@bib16]) since its family member Piezo1 has originally been described to reside in the endoplasmic reticulum ([@bib52]). Thus, exploring endocytosis and intracellular trafficking of Piezo2 may offer novel insights into its regulation by the intracellular membrane pool of PI(3,5)P2.

To address some of these issues the development of high-affinity Mtmr2 and Piezo2 antibodies as well as PI(3,5)P~2~-specific probes ([@bib31]; [@bib47]; [@bib50]; [@bib60]; [@bib64]), which faithfully represent their subcellular spatial and temporal dynamics, would be required. In contrast to PI(4,5)P~2~, such probes have not yet been successfully designed for PI(3,5)P~2~, and the value of the few existing probes is questionable due to spatial restrictions and limited specificity for PI(3,5)P~2~ ([@bib31]; [@bib47]; [@bib50]; [@bib60]; [@bib64]). Future studies using these tools combined with high-resolution microscopy have the potential to address fundamental aspects of Piezo2 trafficking, localization, and function.

Taken together, our data present Mtmr2 as a novel modulator of the mechanosensory apparatus, and we provide evidence for the functional convergence of Mtmr2 enzymatic activity and PI(3,5)P~2~ availability onto Piezo2-mediated mechanotransduction in peripheral sensory neurons. In essence, we propose the Mtmr2-Piezo2 interaction as a previously unappreciated mechanism to locally and dynamically regulate Piezo2 function and, consequently, the organism´s response to light tough. Therefore, our study significantly advances our understanding of the complex molecular machinery underlying somatosensory mechanosensitivity in vertebrates.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\             Designation                                Source or reference                  Identifiers                                                               Additional information
  or resource                                                                                                                                                                                   
  ----------------------------------- ------------------------------------------ ------------------------------------ ------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------
  Strain, strain background (mouse)   B6/J mice                                                                       RRID: [IMSR_JAX:000664](https://scicrunch.org/resolver/IMSR_JAX:000664)   bred in the animal facility of the MPIem Goettingen

  Strain (mouse)                      Piezo2GFP                                  kind gift of Ardem Patapoutian                                                                                 bred in the animal facility of the MPIem Goettingen

  Cell line (human)                   HEK293                                     purchased from ATCC                  RRID: [CVCL_0045](https://scicrunch.org/resolver/CVCL_0045)               Cells were not tested for mycoplasma contamination; cells were authenticated by ATCC upon purchase

  Antibody                            Rabbit anti-Mtmr2 (1:100)                  Biotechne, \#NBP1-33724              RRID: [AB_2147841](https://scicrunch.org/resolver/AB_2147841)             

                                      Chicken anti-GFP (1:500)                   Thermo Fisher Scientific, \#A10262   RRID: [AB_2534023](https://scicrunch.org/resolver/AB_2534023)             

                                      Rabbit anti-GST (1:500)                    Santa Cruz, \#sc-459                                                                                           

                                      Mouse anti-myc (1:750, 1:500)              Santa Cruz, \#sc-47694               RRID: [AB_627266](https://scicrunch.org/resolver/AB_627266)               

                                      Mouse anti-FLAG (1:100)                    Sigma Aldrich, \#F1804               RRID: [AB_262044](https://scicrunch.org/resolver/AB_262044)               

                                      Rabbit anti-Piezo2 (1:200)                 Novus Biologicals, \#NBP1-78624      RRID: [AB_11005294](https://scicrunch.org/resolver/AB_11005294)           

  Recombinant DNA reagent             pCMVSport6 Piezo2-GST IRES GFP             kind gift of Ardem Patapoutian       mouse *Piezo2*                                                            

                                      pCMV6-Entry Mtmr2-myc-DDK                  Origene, \#MR215223                  mouse *Mtmr2*                                                             

                                      Mtmr2C417S-myc-DDK                                                              mouse *Mtmr2 C417S*                                                       Mutation generated using Q5 Site-Directed Mutagenesis kit (New England BioLabs)

                                      pCMV Sport6 Piezo1-753-myc-IRES GFP        kind gift of Ardem Patapoutian       mouse *Piezo1*                                                            Myc tag was inserted at amino acid 753 as described in[@bib17].

                                      pGEM-Teasy Kv1.1-HA                                                             mouse *Kv1.1*                                                             Custom-made and sequence-verified

                                      pCMVSport6                                 kind gift of ArdemPatapoutian                                                                                  

                                      pCDNA3.1-myc-His                           Invitrogen, \#V80020                                                                                           

                                      pCNDA3-GST                                 kind gift of Ardem Patapoutian                                                                                 

                                      pCMVSport6 Piezo2 P1 mutant-GST IRES GFP                                        mouse *Piezo2 P1* mutant                                                  Mutation generated using Q5 Site-Directed Mutagenesis kit (New England BioLabs)

                                      pCDNA3.1-myc-His TRPA1                     kind gift of Ardem Patapoutian       mouse TRPA1                                                               

                                      pCMV6-Vti1b-myc-DDK                        Origene                                                                                                        

  Sequence-based reagent              *Mtmr2* forward primer for qPCR            MPIem DNA Core Facility              TGTACCCCACCATTGAAGAAA                                                     

                                      *Mtmr2* reverse primer for qPCR            MPIem DNA Core Facility              TAAGAGCCCCTGCAAGAATG                                                      

                                      *Piezo2* forward primer for qPCR           MPIem DNA Core Facility              AGGCAGCACATAGGATGGAT                                                      

                                      *Piezo2* reverse primer for qPCR           MPIem DNA Core Facility              GCAGGGTCGCTTCAGTGTA                                                       

                                      *Actb* forward primer for qPCR             MPIem DNA Core Facility              GATCAAGATCATTGCTCCTCCTG                                                   

                                      *Actb* reverse primer for qPCR             MPIem DNA Core Facility              CAGCTCAGTAACAGTCCGCC                                                      

                                      *Gapdh* forward primer for qPCR            MPIem DNA Core Facility              CAATGAATACGGCTACAGCAAC                                                    

                                      *Gapdh* reverse primer for qPCR            MPIem DNA Core Facility              TTACTCCTTGGAGGCCATGT                                                      

                                      *Piezo2* mutagenesis forward primer        MPIem DNA Core Facility              GTCTTCTGGTGGCTCGTGGTCATTTATACCATGTTGG                                     

                                      *Piezo2* mutagenesis reverse primer        MPIem DNA Core Facility              ACGCAGCAGCTTCCTCCACCACTCGTAGTGCAC                                         

                                      *Mtmr2* mutagenesis forward primer         MPIem DNA Core Facility              GTGGTACACTCCAGTGATGGATG                                                   

                                      *Mtmr2*mutagenesis reverse primer          MPIem DNA Core Facility              CACAGACGTCTTCCCAGA                                                        

  Peptide, recombinant protein        Piezo2-FLAG tagged                         Custom-made by GenScript             EWWRKILKYFWMSVVIDYKDDDDKQNN                                               

                                      Piezo2 3Q-FLAG tagged                      Custom-made by GenScript             EWWQQILQYFWMSVVIDYKDDDDKQNN                                               

                                      Piezo1-FLAG tagged                         Custom-made by GenScript             TLWRKLLRVFWWLVDYKDDDDKQNN                                                 

  Chemical compound, drug             Wortmannin                                 Sigma Aldrich                                                                                                  

                                      Apilimod                                   Bertin Pharma                                                                                                  

                                      PI(3,5)P2                                  Echelon                                                                                                        

                                      PI(3)P                                     Echelon                                                                                                        

  Software, algorithm                 Fitmaster                                  HEKA Electronik GmbH                                                                                           

                                      Patchmaster                                HEKA Electronik GmbH                                                                                           

                                      ImageJ                                     NIH ([@bib73])                       RRID: [SCR_003070](https://scicrunch.org/resolver/SCR_003070)             

                                      GraphPad Prism 6.01                        GraphPad Software                    RRID: [SCR_015807](https://scicrunch.org/resolver/SCR_015807)             
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

DRG culture and transfection {#s4-1}
----------------------------

Preparation and culture of mouse DRG neurons were performed as described previously ([@bib16]; [@bib57]). Throughout the study, DRG were isolated from 9 to 10 week old male C57BL/6J mice or, in case of experiments in [Figure 1a](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1a,c](#fig1s1){ref-type="fig"}, [Figure 2---figure supplement 1c,d](#fig2s1){ref-type="fig"} from *Piezo2^GFP^* mice ([@bib83]). In brief, DRG neurons were promptly isolated and digested with collagenase (Thermo Fisher Scientific, Germany) and papain (Worthington, Lakewood, USA). Neurons were plated on poly-D-lysine (1 mg/mL, Merck Millipore, Germany) coated coverslips, which were additionally coated with laminin (20 µg/mL, Thermo Fisher Scientific). Growth medium (Hams F12/DMEM 1:1 ratio with L-glutamine; Gibco, Germany) was supplemented with 10% horse serum (Thermo Fisher Scientific) and 100 ng/ml NGF, 50 ng/ml GDNF, 50 ng/ml BDNF, 50 ng/ml NT-3, and 50 ng/ml NT-4 (all growth factors were procured from R&D Systems, Germany).

Transfection of neurons was achieved by nucleofection of siRNA or plasmid into freshly isolated DRG neurons using the P3 Primary Cell 4D Nucleofector X Kit with the 4D-Nucleofector X Unit according to the manufacturer\'s instructions (Lonza, Germany). 500 nM FlexiTube GeneSolution *Mtmr2* siRNA (Qiagen, \#GS77116, Germany) or AllStar Negative control siRNA (CTRL, Qiagen, \#SI03650318) for knockdown in DRG neurons and 0.5 µg of pCMV6 *Mtmr2-myc-DDK* (Origene) or 0.5 µg of pCMVSport6 or pcDNA3.1 myc-His (CTRL) for overexpression in DRG neurons, was used. After nucleofection, neurons were allowed to recover in calcium free RPMI medium (Thermo Fisher Scientific) for 10 min at 37°C before plating in growth medium. Two hours after transfection half of the growth medium was exchanged with fresh medium and neurons were grown for 48--72 hr before being used for electrophysiology, immunostaining or qPCR.

HEK293 cell culture and transfection {#s4-2}
------------------------------------

HEK293 cells were authenticated by ATCC (Manassas, USA) upon purchase. Thereafter, cell line identity was authenticated by regular morphological inspection. Symptoms for mycoplasma contamination were not observed and thus no test for mycoplasma contamination was performed. Cells were cultured in DMEM with Glutamax (Thermo Fisher Scientific) supplemented with 10% FBS (Fetal bovine serum, Thermo Fisher Scientific) and 5% Pen/Strep (Thermo Fisher Scientific). Cells were grown up to 80--90% confluence before being used for transfection. Transfection was done using Fugene HD Transfection reagent (Promega, Germany). Cells were plated on poly-D-lysine-coated coverslips and maintained in culture for 48 hr before being used for electrophysiology or proximity ligation assay (PLA).

cDNA and plasmids {#s4-3}
-----------------

pCMVSport6 *Piezo2-GST*-IRES GFP (kind gift from Prof. Ardem Patapoutian, La Jolla, USA); pCMV6-Entry *Mtmr2-myc-DDK* (Origene, \#MR215223); pCMV6-Entry *Mtmr2C417S-myc-DDK* (mutation as described in ([@bib3]); pCMV Sport6 *Piezo1-753-myc*-IRES GFP (kind gift from Ardem Patapoutian) ([@bib17]); pGEM-Teasy *Kv1.1-HA*; pCMVSport6; pCDNA3.1-myc-His (Invitrogen, \#V80020); pCNDA3-GST (kind gift from Prof. Ardem Patapoutian); pCMVSport6 *Piezo2 P1 mutant-GST*-IRES GFP. *Mtmr2C417S* mutant and *Piezo2 P1* mutant were prepared using Q5 Site-Directed Mutagenesis kit (New England BioLabs). Mutagenesis was done according to manufactures instructions and all mutant plasmids were verified by sequencing. Primers used for the mutagenesis were as follows: *Mtmr2* mutagenesis forward primer: GTGGTACACTCCAGTGATGGATG; *Mtmr2* mutagenesis reverse primer: CACAGACGTCTTCCCAGA; *Piezo2* mutagenesis forward primer: GTCTTCTGGTGGCTCGTGGTCATTTATACCATGTTGG; *Piezo2* mutagenesis reverse primer: ACGCAGCAGCTTCCTCCACCACTCGTAGTGCAC.

Quantitative PCR (qPCR) {#s4-4}
-----------------------

Total RNA was isolated from cultured DRG neurons (transfected with *Mtmr2* siRNA or CTRL, please see above), using NucleoSpin RNA XS (Macherey-Nagel) according to the manufacturer\'s instructions. First-strand cDNA synthesis was done using QuantiTect reverse transcription kit (Qiagen). Mtmr2 and Piezo2 gene expression was assessed in both conditions by real-time qPCR using the SYBR green system (Power SYBR Green PCR Master Mix; Thermo Fisher Scientific) on a LightCycler 480 instrument (Roche, Germany). The melting curve analysis of amplified products was used to confirm the specificity of qPCR assay. All samples were run in triplicate and negative control reactions were run without template. Threshold cycle (Ct) values, the cycle number in which SYBR green fluorescence rises above background, were normalized to two reference genes (*Actb* and *Gapdh*) and recorded as a measure of initial transcript amount. Relative quantification was performed using the 'fit point' as well as the 'second derivative maximum' method of the LightCycler 480. Primer sequences 5′−3′ are the following: *Mtmr2* (fw: tgtaccccaccattgaagaaa; rev: taagagcccctgcaagaatg), *Piezo2* (fw: aggcagcacataggatggat; rev: gcagggtcgcttcagtgta), *Actb* (fw: gatcaagatcattgctcctcctg; rev: cagctcagtaacagtccgcc), *Gapdh* (fw: caatgaatacggctacagcaac; rev: ttactccttggaggccatgt). Of note, only data normalized to *Actb* are shown but data normalized to *Gapdh* gave similar results. Our qPCR results indicate successful siRNA-mediated knockdown of Mtmr2 across the whole coverslip, which also includes non-transfected neurons and glia cells. Therefore our data do not report on the transfection efficiency and extent of Mtmr2 knockdown in individual neurons.

Electrophysiology {#s4-5}
-----------------

Whole-cell voltage clamp recordings were performed in transfected DRG cultures, wild type DRG cultures or transfected HEK293 cell cultures at room temperature as described in ([@bib57]). Briefly, (protocol adapted from \[[@bib16]\]) to elicit mechanically activated currents, the cell soma was mechanically stimulated using a blunt probe (fire polished borosilicate glass capillary). The stimulation was delivered using a piezo-electrically driven micromanipulator (Physik Instrumente GmbH and Co.KG, Germany). The probe was initially positioned \~4 µm from the cell body and had a velocity of 0.8 µm/ms during the ramp phase (forward motion). The stimulus was applied for 150 ms with an inter-stimulus interval of 180 ms. Stimulus-current measurements were performed using mechanical stimulations from 0 to 6 µm in 1 µm increments at a holding potential of −70 mV in whole cell mode. All recordings other than specifically indicated were made in standard extracellular solution containing (in mM) 127 NaCl, 3 KCl, 1 MgCl~2~, 2.5 CaCl~2~, 10 Glucose and 10 HEPES; pH = 7.3; osmolarity = 285 mOsm ([@bib16]). To achieve hypotonicity the extracellular solution was adjusted to 160 mOsm. The intracellular solution for DRG neurons contained (in mM) 133 CsCl, 10 HEPES, 5 EGTA, 1 MgCl~2~, 1 CaCl~2~, 4 MgATP and 0.4 NaGTP; pH = 7.3; osmolarity = 280 mOsm ([@bib16]). Hypotonic intracellular solution contained (in mM) 65 CsCl, 10 HEPES, 5 EGTA, 1 MgCl~2~, 1 CaCl~2~, 4 MgATP and 0.4 NaGTP; pH = 7.3; osmolarity = 162 mOsm. Intracellular solution for HEK293 cells contained (in mM) 110 KCl, 10 NaCl, 1 MgCl~2,~ 1 EGTA and 10 HEPES; pH = 7.3 ([@bib63]). Based on protocols published elsewhere ([@bib38]) recordings in extracellular hypotonic solutions were performed as follows: Cells were incubated with the hypotonic solution for 5 min at 37°C prior to recording, after which RA-MA currents were recorded in hypotonic extracellular solution between 0--20 min after initial application. For some experiments described in this study, DRG neurons were treated with chemical inhibitors of the phosphatidylinositol phosphate pathway. Cells were treated with 35 µM Wortmannin (Sigma Aldrich; protocol adapted from \[[@bib55]\]) in DMSO or 1 µM Apilimod (Bertin Pharma, Germany ; protocol adapted from \[[@bib54]\]) in DMSO for 2 hr prior to recording. DMSO (0.08% for Apilimod and 0.35% for Wortmannin), was used as vehicle for each experiment. For PIP addition experiments, 1 µM PI(3,5)P~2~ (Echelon) or 1 µM PI(3)P (Echelon) were included in the isotonic intracellular solution (protocol adapted from \[[@bib21]\]). Of note, the water-soluble diC8 form of the lipids was used as indicated elsewhere ([@bib21]).

Data analysis and representation was done using Fitmaster (HEKA Electonik GmbH, Germany) and Igor Pro 6.37 (WaveMetrics, USA). The current magnitude was calculated by measuring peak amplitudes (at each stimulus point) and subtracting leak current.

The displacement threshold was defined as the minimum displacement required to elicit a visible RA-MA current, that is the displacement at which current values exceeded 100 pA in DRG ([@bib38]; [@bib57]) and 50 pA in HEK293 cells ([@bib76]). In HEK293 cells, this cutoff also served to prevent contamination of recordings by HEK293 endogenous Piezo1 ([@bib24]; [@bib76]). Of note, responses in HEK293 cells increased proportionally to stimulus strength and were absent in cells not transfected with *Piezo1* or *Piezo2* plasmids.

For measurements of inactivation kinetics current traces reaching at least 75% of maximal current amplitude were fitted with a mono-exponential or bi-exponential equation and the fast time constant was used for analysis ([@bib16]). Data for the displacement threshold and inactivation time constant (τ) are provided in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

In DRG cultures neuronal soma size differs considerably within a coverslip. Therefore neurons have been traditionally categorized into small, medium and large diameter neurons ([@bib23]; [@bib35]; [@bib61]; [@bib83])exhibiting well-reported differences in function and MA currents ([@bib23]; [@bib35]; [@bib61]; [@bib63]; [@bib83]). To account for variability of our data due to soma size, we (i) recorded RA currents from visibly large diameter neurons (cell capacitance \>40 pF) likely representing mechanoreceptors ([@bib23]; [@bib35]; [@bib63]; [@bib83]), (ii) analyzed SA currents from small diameter neurons (cell capacitance \<30 pF) likely representing nociceptors ([@bib23]; [@bib35]; [@bib63]; [@bib83]) and (iii) additionally normalized all obtained current data to the individual cell capacitance to obtain a value for current density (pA/pF). The latter analysis (data not shown) yielded similar results as the presented analysis based on current amplitudes for all DRG datasets in this manuscript. IA currents were randomly recorded across all neuron sizes.

Of note, current amplitudes and displacement thresholds cannot be compared among experimental datasets because of differential treatments (e.g. nucleofection, inhibitors) requiring measurements at different culture days in vitro (DIV), and due to the inherent variability in DRG cultures dependent on mouse cohorts used throughout the course of this study. For this reason each dataset consists of experiments and respective controls measured in parallel (i) in the same mouse cohort and (ii), where possible, on each experimental day. For each dataset (experimental versus control conditions) several coverslips from at least 4 (range: 4--18) independent cell cultures or 2--12 independent platings of HEK293 cells were used.

Immunostaining and analysis {#s4-6}
---------------------------

Immunostaining was carried out as described ([@bib57]). Briefly, *Piezo2^GFP^* mice ([@bib83]) (ages 8--9 weeks) were euthanized with CO~2~ or perfused with 4% PFA (Science Services). DRG neurons were isolated and cultured using the protocol described above or DRG were carefully dissected, collected in 4% PFA/1X PBS, and post-fixed for 30 min at 4°C. After overnight cryoprotection in 30% sucrose tissues were frozen in optimal cutting temperature medium, sectioned with a cryostat into 10 μm thick sections, mounted on SuperFrost Plus slides, and stored at −80°C. Frozen slides were thawed at room temperature for 30 min, washed thrice with 1X PBS, blocked for 30 min in 1X PBS containing 5% goat or donkey serum (Dianova, Germany) and 0.4% TritonX-100 (Roth), and incubated with primary antibodies (diluted in 0.1% TritonX-100% and 1% serum in 1X PBS), overnight at 4°C. The sections were then washed with 1X PBS and incubated for 2 hr at room temperature with secondary antibodies diluted 1:250 in 0.1% TritonX-100% and 1% serum in 1X PBS. Sections were then washed six times with 1X PBS and mounted in SlowFade Gold antifade reagent with DAPI (Thermo Fisher Scientific).

For cultured DRG neurons, coverslips containing cells were washed with 1X PBS and fixed in 4% PFA for 10 min. Thereafter cells were washed with 1X PBS and blocked with blocking solution containing 5% serum and 0.4% TritonX-100. Cells were then incubated with primary antibodies (diluted in 1% serum and 0.1% TritonX-100), overnight at 4°C. Cells were then washed with 1X PBS and incubated with secondary antibodies (diluted in 1% serum and 0.1% TritonX-100) for 2 hr at room temperature followed by additional washes. Coverslips were mounted onto SuperFrost Plus slides using SlowFade Gold reagent with DAPI (Thermo Fisher Scientific).

WGA staining to mark membranes of cells was done as follows; before fixation, the cells were treated with WGA-555 (1:200) for 15 min at 37°C. Cells were then washed three times with medium and the standard immunostaining protocol was performed.

Imaging was done using a Zeiss Axio Observer Z1 inverted microscope or a Zeiss LSM 510 Meta Confocal microscope. All images were processed and analyzed by ImageJ, NIH ([@bib73]).

For the analysis of Mtmr2 in cryo-frozen sections or primary cultures of DRGs from *Piezo2^GFP^* mouse, sections were stained with anti-GFP and anti-Mtmr2 antibodies. Positive cells were identified by setting the threshold as 'mean intensity +3\*standard deviation' of randomly selected (\~10) negative cells. The numbers of positive and negative cells were counted using the 'cell counter' plugin of ImageJ. Only for presentation purposes brightness, contrast and levels of images were adjusted in Adobe Photoshop. In all cases image adjustments were applied equally across the entire image and equally to controls.

For the analysis of membrane intensity of Piezo2-GFP upon Mtmr2 knockdown, the 'analyze particle tool' from ImageJ was used. The WGA staining was used to mark the region of interest around the cell membrane and for each ROI, the mean intensity (arbitrary units, AU) and area of positive signal was determined. The mean intensity of signal (arbitrary units, AU) was calculated by subtracting the threshold (defined as 'mean +3\*standard deviation' of background) from the total mean intensity.

Proximity ligation assay (PLA) {#s4-7}
------------------------------

PLA was carried out as described ([@bib32]; [@bib57]) with minor modifications. HEK293 cells or DRG neurons were plated on MatTek dishes coated with poly-D-lysine (and Laminin for DRG neuron cultures) and transfected with appropriate plasmids (details of plasmids are provided below). Cells were cultured for 48 hr before staining. Cells were washed with 1X PBS and fixed with 4% PFA for 10 min at room temperature. Thereafter cells were blocked in Duolink Blocking Solution (Sigma Aldrich, Germany) for 2 hr at room temperature. Cells were then incubated with primary antibodies (diluted in Duolink Antibody Diluent (Sigma Aldrich)), overnight at 4°C. Cells were washed with wash buffer A (0.01 M Tris, 0.15 M NaCl and 0.05% Tween 20, pH 7.4) and incubated with PLA probes (PLUS and MINUS probes were diluted 1:10 in Duolink antibody diluent (Sigma Aldrich)) for 1 hr at 37°C. Cells were washed again with wash buffer A and incubated with amplification mix (amplification stock 1:5 and polymerase 1:80 in water) for 100 min at 37°C. Cells were then washed with wash buffer B (0.2 M Tris, 0.1 M NaCl, pH7.5) and stored in 1X PBS before imaging. Secondary controls meant omitting all primary antibodies.

Plasmids used: pCMVSport6 *Piezo2-GST*-IRES-GFP (kind gift from Prof. Ardem Patapoutian); pCMV6-Entry *Mtmr2-myc-DDK* (Origene, \#MR215223); pCMV6-Entry *Mtmr2C417S-mycDDK*, mutation as described by Berger and colleagues ([@bib3]), was custom-generated using the Q5 Site-Directed Mutagenesis kit (New England BioLabs); pCMVSport6; pCDNA3.1-myc-His (Invitrogen, \#V80020); pmaxGFPVector (Lonza).

The PLA was imaged using a Zeiss Axio Observer Z1 inverted microscope. The imaging settings were constant across all samples of the same experiments. Secondary controls were always imaged in parallel using the same settings. Image analysis was done using ImageJ. The background was determined as the 'mean intensity +3\*standard deviation' of randomly chosen negative cells per field of view and averaged for all images within one condition. The highest background value was then used as threshold for the analysis. GFP positive cells (from Piezo2-GST-IRES-GFP expression or pmaxGFPVector) were chosen for each field of view and the PLA signal was analyzed for these cells, using the 'Analyze Particle' tool of ImageJ. The number of PLA puncta and total area of positive PLA signal for each cell was measured. To account for variability in cell size, the total area of the cell was also measured and the PLA signal values were normalized to total cell area. Only for presentation purposes brightness, levels and contrast of images were adjusted in Adobe Photoshop. In all cases image adjustments were applied equally across the entire image and equally to controls. Experiments were performed on several coverslips of at least two independently transfected HEK293 and DRG cultures, respectively.

Atomic force microscopy (AFM) {#s4-8}
-----------------------------

DRG neurons were nucleofected with AllStar Negative control siRNA (CTRL) or *Mtmr2* siRNA, as described above, and maintained in culture for 72 hr. Elasticity and tether force measurements were performed with an AFM (MFP-3D extended head, Asylum Research, Germany) mounted on an inverted microscope (IX71, Olympus, Germany) using contact mode with a triangular cantilever comprising a pyramidal tip (TR-400-PB, Olympus). During the measurements cells were maintained in growth media. The spring constant of the cantilever was determined using the built in thermal method (24--28 pN/nm). Indentation and retraction speed was kept constant at 5 µm/s, and force load of 200--1000 pN was used to measure the Young's modulus of the cells. The effective Young's modulus E~eff~ was fitted with a modified Hertz model using a self-written IGOR macro ([@bib70]). Tether forces were determined as the difference of pulling force before and after rupture of a tether from the AFM tip using a semi-automated step finding procedure ([@bib58]).

Bioinformatic identification of PIP2 binding regions in Piezo2 {#s4-9}
--------------------------------------------------------------

TRPML1 is known to bind PI(3,5)P~2~ through a region in its N-terminus ([@bib21]). This region of TRPML1 (NP_444407.1) was compared to mouse Piezo2 (NP_001034574.4) and mouse Piezo1 (NP_001032375.1) using NCBI protein Blast (National Library of Medicine (US), National Center for Biotechnology Information).

Peptide-lipid binding assay {#s4-10}
---------------------------

The protocol was adapted from ([@bib3]) with minor modifications. In brief, PIP strips (Echelon Biosciences, Inc., Salt Lake City, USA) were washed once with PBS-T (1x PBS + 1% Tween) and blocked with 3% fat free BSA (bovine serum albumin; Sigma Aldrich) in 1X PBS for 1 hr at room temperature. The membranes were then incubated with 0.5 µg/mL peptide solution (peptide dissolved in 1% BSA) for 2 hr at room temperature. Experiments and controls were processed in parallel. Membranes were washed with PBS-T three times for 7 min each and then incubated with primary antibody at room temperature for 2 hr. Membranes were then washed with PBS-T and probed with secondary antibodies coupled with Alexa680 for 1 hr at room temperature. Imaging was done on the Odyssey Infrared System (LI-COR, Germany). Only for presentation purposes brightness, gradient levels and contrast of images were adjusted in Adobe Photoshop. In all cases image adjustments were applied equally across the entire image and equally to controls.

Peptides {#s4-11}
--------

The following peptides were used in this study (all procured from GenScript, New Jersey, USA): Piezo2 (731-746)-FLAG tagged \[EWWRKILKYFWMSVVIDYKDDDDKQNN\]; Piezo2 3Q mutant (731-746)-FLAG tagged \[EWWQQILQYFWMSVVIDYKDDDDKQNN\]; Piezo1 (626-639)-FLAG tagged \[TLWRKLLRVFWWLVDYKDDDDKqnn\].

Antibodies {#s4-12}
----------

The following antibodies were used in this study: 1:100 rabbit anti-Mtmr2 (Biotechne, Minneapolis, USA; \#NBP1-33724); 1:500 chicken anti-GFP (Thermo Fisher Scientific, \#A10262); 1:250 (Immunocytochemistry), 1:500 (PLA) rabbit anti-GST (Santa Cruz, Santa Cruz, USA; \#sc-459); 1:100 (immunocytochemistry and immunoblotting), 1:750, 1:500 (PLA in HEK293 cells and DRG neurons respectively) mouse anti-myc (Santa Cruz, \#sc-47694); 1:200 Rabbit anti-Piezo2 (Novus Biologicals, Germany; \#NBP1-78624); 1:500 mouse anti-FLAG (Sigma Aldrich, \#F1804), Secondary antibodies conjugated to Alexa Fluor 488, Alexa Fluor 546, Alexa Fluor 647, Alexa Fluor 680 (Thermo Fisher Scientific), Duolink in situ PLA probes 1:10 anti-rabbit MINUS, 1:10 anti-mouse PLUS.

Statistics {#s4-13}
----------

Data was analyzed using GraphPad Prism 6.01 (San Diego, USA). All data are represented as mean ± SEM (standard error of mean) unless indicated otherwise. All replicates were biological. All statistical tests are two-sided unless indicated otherwise. In all panels: ns \> 0.05; **~\*~**p≤0.05; **~\*\*~**p≤0.01; **~\*\*\*~**p≤0.001; **~\*\*\*\*~**p≤0.0001).

PLA data: Mann-Whitney test or Kruskal-Wallis test with Dunn's Multiple Comparison test.

Atomic force microscopy (AFM) data: Mann-Whitney test. qPCR: One sample t-test was used (values were compared to a theoretical mean of 1.00, that is mRNA expression in CTRL).

Immunostaining: For membrane Piezo2 expression and number of Piezo2-positive neurons upon Mtmr2 knockdown, the Mann-Whitney test was used.

Peptide-lipid binding assays: One-way ANOVA followed by Dunnett´s or Holm-Sidak's multiple comparisons test was used as indicated.

Electrophysiology: For the analysis of stimulus-current curves, 2-way ANOVA with Holm-Sidak's multiple comparisons test was used. The P-value represents the results of 2-way ANOVA, testing the overall effect of the respective treatment. Results of the Holm-Sidak's multiple comparisons test are represented by p-values and indicated in each legend. Outlier analysis was carried out using the Grubb's test followed by testing whether the outlier value exceeded 'mean +3\* standard deviation'. Outlier analysis was only performed on current values at maximal stimulation. Only if a value met both criteria (Grubb's outlier and \>'mean +3\*standard deviation') the cell was excluded from further analysis. Datasets, where a single outlier was removed: [Figure 1h](#fig1){ref-type="fig"}, [Figure 2b](#fig2){ref-type="fig"}, [Figure 4b](#fig4){ref-type="fig"}, [Figure 4d](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1a,c](#fig4s1){ref-type="fig"}. For the analysis of the displacement threshold and inactivation time constant the Mann-Whitney test was used, unless more than two groups were compared, for which one-way ANOVA or Kruskal-Wallis test followed by Dunn's multiple comparisons test were used. For the analysis of mechanically activated (MA) current populations Chi-square test was used and data are represented as % of all analyzed cells.
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###### Summary of properties of MA currents elicited under various conditions in HEK293 cells and DRG neurons

The table shows the displacement threshold and inactivation time constant (τ) values for all electrophysiological data presented in this study (please see Materials and methods for details on the calculation of each value). Values are represented as mean ± SEM and cell numbers are indicated by 'n'. Data were not significant (ns) unless otherwise mentioned. Please note: for SA-MA currents, it was not possible to fit the current traces of all cells with a mono or bi-exponential fit (please see Materials and methods for details), hence the cell numbers measured for the inactivation time constant (τ) are lower than actual cell numbers measured and reported in [Figure 2](#fig2){ref-type="fig"}.
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Patricia
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France

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Mtmr2 and PI(3,5)P~2~ interdependently control Piezo2-mediated mechanotransduction in peripheral sensory neurons\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Richard Aldrich as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

All three reviewers appreciated, very much, the concept of investigating membrane modulators of Piezos, which they consider as significant and timely. However, they raised strong concerns on your skin-nerve and behavior experiments.

Summary:

This manuscript reports a mechanism by which mechanically-activated Piezo2 ion channels are modulated by myotubularin-related protein-2 (Mtmr2) and PI(3,5)P~2~. Whereas Mtmr2 is a protein the same group recently identified as a novel interaction partner of Piezo2, the work here uncovers the functional significance. The data show that Mtmr2 through PI(3,5)P~2~ production regulates Piezo2 currents in HEK293 cells and DRG neurons, and present evidence for a binding site on Piezo2 for cellular PI(3,5)P~2~.

Essential revisions:

Overall, the area of work is of interest for the mechanotransduction field, as relatively little mechanistic information is known about how changes in the lipid membrane can affect somatosensation or how mechanotransduction channels are modulated. In addition to that, Mtmr2 has not been studied and the modulation of Piezo2 after injury is not well understood.

However, in its current form, although the manuscript is well written, it is difficult to conceptualize the mechanism that is proposed. The reviewers recognize that the lack of mechanistic framework is largely due to the inherent difficulty of the problem and the lack of tools. Moreover, strong concerns were raised about the skin-nerve and animal behavior experiments. For these reasons, the editor and the reviewers propose the following revisions to improve the message and strength of the manuscript.

1\) Strong concerns about the skin-nerve and animal behavior experiments.

Using hypoosmotic stresses in vivo is not a classical approach to mimic tactile hypersensitivity rather than a more standard injury model that is typically used on the somatosensory field. Moreover, nerve recordings of the SA-Aβ fibers do not look like other published recordings of SA-Aβ fibers because their maximum stimulus response increases are not in the 5-20 mN range, which is typical for SA-Aβ fibers. There is concern that these recordings might have missed the ideal spot of the receptive field. The 200-300 mN range is too high for SA-Aβ fibers, and this atypical range is where effects on SA-Aβ could all be due to tissue damage (the abnormally high mechanical stimulus together with hypoosmotic stimuli). Even if these problems could be correctly addressed, since the basic mechanism is not clearly established, the in vivo results are difficult to interpret, as these effects can be due to a myriad of mechanisms other than Piezo2 regulation. For all of these reasons, we recommend deleting the skin nerve and animal behavioral assays aspect of your manuscript and to reinforce the mechanistic interactions as detailed below.

2\) A key point would be to establish more precisely the specificity of Piezo2 for PI(3,5)P~2~ by performing new experiments with mutants.

Between mouse Piezo1 and Piezo2 the amino acid similarity within and proximal to this specific domain is extremely high:

Piezo1 LFLLCLTLFQVYYSLWRKLLKAFWWLVVAYTMLVLIAVYTFQFQDFP 661.

Piezo2 LFLFCVALYQVHYEWWRKILKYFWMSVVIYTMLVLIFIYTYQFENFP 768.

The questions to test are the following:

a\) Can a Piezo1 peptide (RKLLKAFWWL) bind PI(3,5)P~2~?

b\) Is a Piezo2 channel deficient in PI(3,5)P~2~ binding when mutated into the Piezo1 sequence (RKLLKAFWWL)?

c\) Can Piezo1 be rendered into an Mtmr2-dependent channel by mutating it into the Piezo2 sequence (RKILKYFWMS)?

3\) For the lipid binding data that are key to the paper, more quantification should be performed, since large batch to batch variability is a common issue and relying on a representative of n=3 is not very rigorous. It is important to show statistical summary. Moreover, it is very important to do same day controls with the Piezo1 and Piezo2 peptides.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Myotubularin related protein 2 and its phospholipid substrate PIP~2~ control Piezo2-mediated mechanotransduction in peripheral sensory neurons\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Richard Aldrich (Senior editor), a Reviewing editor, and two reviewers.

The manuscript has been improved but there are some remaining minor issues that need to be addressed before acceptance, as outlined below. Please add some lines of text to emphasise the two points.

1\) The PLA \"negative\" controls show a clear signal, even though less than with Mtmr (Figure 1---figure supplement 1), confirming my suspicion about this technique. The authors show this in the supplemental figure but ignore it in the main text. I think it would be beneficial for the scientific community to draw attention to the propensity of this technique to produce artifacts especially in transfection systems. I think improper use of statistics is only a small part of the reproducibility crisis. Not being aware of the limitations of techniques is equally or even more important.

2\) PI(3,5)P~2~ is thought to be mainly in intracellular membranes. The discussion acknowledges it but does so in the vaguest possible manner. I would probably be a little more direct and discuss this potential contradiction. It may trigger some future experiments to figure out what is going on.

10.7554/eLife.32346.019

Author response

> Essential revisions:
>
> Overall, the area of work is of interest for the mechanotransduction field, as relatively little mechanistic information is known about how changes in the lipid membrane can affect somatosensation or how mechanotransduction channels are modulated. In addition to that, Mtmr2 has not been studied and the modulation of Piezo2 after injury is not well understood.
>
> However, in its current form, although the manuscript is well written, it is difficult to conceptualize the mechanism that is proposed. The reviewers recognize that the lack of mechanistic framework is largely due to the inherent difficulty of the problem and the lack of tools. Moreover, strong concerns were raised about the skin-nerve and animal behavior experiments. For these reasons, the editor and the reviewers propose the following revisions to improve the message and strength of the manuscript.
>
> 1\) Strong concerns about the skin-nerve and animal behavior experiments.
>
> Using hypoosmotic stresses in vivo is not a classical approach to mimic tactile hypersensitivity rather than a more standard injury model that is typically used on the somatosensory field. Moreover, nerve recordings of the SA-Aβ fibers do not look like other published recordings of SA-Aβ fibers because their maximum stimulus response increases are not in the 5-20 mN range, which is typical for SA-Aβ fibers. There is concern that these recordings might have missed the ideal spot of the receptive field. The 200-300 mN range is too high for SA-Aβ fibers, and this atypical range is where effects on SA-Aβ could all be due to tissue damage (the abnormally high mechanical stimulus together with hypoosmotic stimuli). Even if these problems could be correctly addressed, since the basic mechanism is not clearly established, the in vivo results are difficult to interpret, as these effects can be due to a myriad of mechanisms other than Piezo2 regulation. For all of these reasons, we recommend deleting the skin nerve and animal behavioral assays aspect of your manuscript and to reinforce the mechanistic interactions as detailed below.

We completely agree with the reviewers on the point that results of both experiments are difficult to interpret and might additionally reflect Piezo2-independent processes. We followed the reviewers´ suggestions and deleted the skin-nerve and animal behavioral assays from the revised manuscript.

> 2\) A key point would be to establish more precisely the specificity of Piezo2 for PI(3,5)P~2~ by performing new experiments with mutants.
>
> Between mouse Piezo1 and Piezo2 the amino acid similarity within and proximal to this specific domain is extremely high:
>
> Piezo1 LFLLCLTLFQVYYSLWRKLLKAFWWLVVAYTMLVLIAVYTFQFQDFP 661.
>
> Piezo2 LFLFCVALYQVHYEWWRKILKYFWMSVVIYTMLVLIFIYTYQFENFP 768.
>
> The questions to test are the following:
>
> a\) Can a Piezo1 peptide (RKLLKAFWWL) bind PI(3,5)P~2~?

Can a mouse Piezo1 peptide (mouse Piezo1 sequence: RKLLRVFWWL, please note that the sequence indicated by the reviewers represents the corresponding human Piezo1 region) bind PI(3,5)P~2~?

We tested this using lipid-peptide binding assays and did not observe any evidence that the corresponding region of mouse Piezo1 can bind any of the tested lipids including PI(3,5)P~2~. These experiments were always performed in parallel with additional experiments using the mouse Piezo2 peptide (serving as positive control) and the Piezo2 3Q mutant peptide. These data are included and discussed in the revised manuscript: Figure 5C,D; Subsection "Piezo2 harbors a PIP2 binding motif"; Discussion section.

> b\) Is a Piezo2 channel deficient in PI(3,5)P~2~ binding when mutated into the Piezo1 sequence (RKLLKAFWWL)?
>
> c\) Can Piezo1 be rendered into an Mtmr2-dependent channel by mutating it into the Piezo2 sequence (RKILKYFWMS)?

These are excellent suggestions and we addressed them with additional experiments.

a\) Can a mouse Piezo1 peptide (mouse Piezo1 sequence: RKLLRVFWWL, please note that the sequence indicated by the reviewers represents the corresponding human Piezo1 region) bind PI(3,5)P~2~?

We tested this using lipid-peptide binding assays and did not observe any evidence that the corresponding region of mouse Piezo1 can bind any of the tested lipids including PI(3,5)P~2~. These experiments were always performed in parallel with additional experiments using the mouse Piezo2 peptide (serving as positive control) and the Piezo2 3Q mutant peptide. These data are included and discussed in the revised manuscript: Figure 5C,D; Subsection "Piezo2 harbors a PIP2 binding motif"; Discussion section.

b\) Is a Piezo2 channel deficient in PI(3,5)P~2~ binding when mutated into the mouse Piezo1 sequence (mouse Piezo1 sequence: RKLLRVFWWL, please note that the sequence indicated by the reviewers belongs to the corresponding human Piezo1 region)?

We generated this Piezo2 P1 mutant, which was functional upon heterologous expression in HEK293 cells. Remarkably, MA currents mediated by the Piezo2 P1 mutant were only slightly attenuated upon co-expression with Mtmr2 compared to mock-transfected controls (Figure 5D). Also, the displacement threshold and inactivation time constant (τ) of MA currents remained unchanged (Supplementary file 1). This result is in stark contrast to the pronounced Mtmr2-induced suppression of MA currents recorded from wildtype Piezo2 (Figure 1F).

Hence, these results suggest that the PI(3,5)P~2~ binding domain we identified in mouse Piezo2 indeed significantly contributes to the sensitivity of Piezo2 to Mtmr2-dependent changes in PI(3,5)P~2~ levels.

These data are included and discussed in the revised manuscript: Figure 5E; subsection "Piezo2 harbors a PIP2 binding motif"; Discussion section.

c\) Can Piezo1 be rendered into an Mtmr2-dependent channel by mutating it into the Piezo2 sequence (RKILKYFWMS)?

We have generated this Piezo1 P2 mutant. Unfortunately, we could not obtain any functional recordings of RA-MA currents from this mutant despite intensive efforts, i.e. we tried to record from \>40 cells from \>7 independent transfections. To exclude any technical issues with recordings, we included the Piezo1 wildtype plasmid as a positive control (the same, which was used in Figure 1---figure supplement 2) and managed to successfully record RA-MA currents in parallel. To assess whether issues with the Piezo1 P2 mutant clone itself might be responsible for the lack of functionality we fully sequenced the Piezo1 P2 mutant, and additionally recloned the mutated region into a non-mutated backbone of pcDNA3.1 Piezo1-IRES-GFP. However, we did not obtain a functional Piezo1 P2 clone as assessed by electrophysiology.

Hence, despite all our efforts, we are not able to provide this dataset in our revised manuscript.

> 3\) For the lipid binding data that are key to the paper, more quantification should be performed, since large batch to batch variability is a common issue and relying on a representative of n=3 is not very rigorous. It is important to show statistical summary. Moreover, it is very important to do same day controls with the Piezo1 and Piezo2 peptides.

This is certainly an important point. Therefore, we (i) added more experimental repetitions using both Piezo2 peptides, (ii) combined these experiments with lipid binding assays using Piezo1 in parallel on the same day (please see our reply to point 2 above), and (iii) added a statistical evaluation for all experiments. Of note, these additional experiments also uncovered weak, but statistically significant binding of the Piezo2 peptide to PI(3,4)P~2~. Taken together, these data suggest that not only positively charged amino acid residues, but also flanking amino acids in this Piezo2 PIP binding region contribute to PIP~2~ binding in a yet to be explored manner. Further, these in vitro binding studies substantiate our functional data on the specific link between Piezo2 and the Mtmr2 substrate PI(3,5)P~2~ by identifying a PI(3,5)P~2~ binding domain in Piezo2, but not in Piezo1.

These data are included and discussed in the revised manuscript: Figure 5B--D; Figure 5---figure supplement 1; Subsection "Piezo2 harbors a PIP2 binding motif"; Discussion section.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The manuscript has been improved but there are some remaining minor issues that need to be addressed before acceptance, as outlined below. Please add some lines of text to emphasise the two points.
>
> 1\) The PLA \"negative\" controls show a clear signal, even though less than with Mtmr (Figure 1---figure supplement 1), confirming my suspicion about this technique. The authors show this in the supplemental figure but ignore it in the main text. I think it would be beneficial for the scientific community to draw attention to the propensity of this technique to produce artifacts especially in transfection systems. I think improper use of statistics is only a small part of the reproducibility crisis. Not being aware of the limitations of techniques is equally or even more important.

The reviewers raise very important points. In the revised version of the manuscript we included a critical evaluation of PLA results in transfected HEK293 cells.

Results section: "For a more detailed subcellular analysis we used the proximity ligation assay (PLA). In this way we could show the close vicinity of Piezo2 and Mtmr2 in both, somata and neurites of cultured DRG neurons, and upon co-transfection in HEK293 cells (Figure 1A--D and Figure 1---figure supplement 1C,D). It is important to note here that the PLA technique is prone to high background upon heterologous expression as shown by our additional control experiments in HEK293 cells (Figure 1---figure supplement 1D). In these we co-overexpressed Piezo2 with TRPA1 and Vti1b, respectively. Both of these controls exhibited clear PLA signal (likely attributable to massive overexpression upon transfection), though less than co-overexpression with Mtmr2 (Figure 1---figure supplement 1D)."

> 2\) PI(3,5)P~2~ is thought to be mainly in intracellular membranes. The discussion acknowledges it but does so in the vaguest possible manner. I would probably be a little more direct and discuss this potential contradiction. It may trigger some future experiments to figure out what is going on.

We now included a more detailed and directed discussion on the possibility that Piezo2 might be regulated in intracellular membranes. Furthermore, we specifically mention this possibility in the legend of Figure 6.

Discussion section: "It remains to be seen whether these membrane compartments are confined to the plasma membrane and/or to intracellular membranes such as endo-lysosomes, which are known to contain the majority of PI(3,5)P~2~ (Di Paolo and De Camilli, 2006; Dong et al., 2010; Zolov et al., 2012). Along these lines it is worth mentioning that AMPA receptor abundance at hippocampal synapses has been shown to be regulated by PI(3,5)P~2~-controlled cycling through early and late endosomes (McCartney et al., 2014). While unknown so far, localization of Piezo2 to intracellular membranes would not be unexpected (Coste et al., 2010) since its family member Piezo1 has originally been described to reside in the endoplasmic reticulum (McHugh et al., 2010). Thus, exploring endocytosis and intracellular trafficking of Piezo2 may offer novel insights into its regulation by the intracellular membrane pool of PI(3,5)P~2~.

Figure legend 6: "This would provide an active mechanism to inhibit Piezo2 RA-MA currents in membrane compartments -- may they be at the plasma membrane or intracellular membranes."
